Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000042

SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $78.85 ($131,449)

  • SVP, GEN COUNSEL & CORP SEC acquired 1,667 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-08-01 Option exercise 10b5-1 +1,667 $21.41 $35,690 32,493 D: show line 1 in the form
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-08-01 Sale 10b5-1 −1,482 $78.80 $116,781 31,011 D: show line 2 in the form
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-08-01 Sale 10b5-1 −185 $79.29 $14,668 30,826 D: show line 3 in the form
Open-market sales · 1,667 sh · avg $78.85 · $131,449

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-08-01 Option exercise · Stock Option (right to buy) 10b5-1 −1,667 181,664 D: show line 4 in the form
Loading xslF345X05/wk-form4_1722888387.xml…